Emergent BioSolutions Inc.
NYSE: EBS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joseph C. Papa Jr.
- Employees
- 900
- Headquarters
- Gaithersburg, United States
- IPO year
- 2006
- Market cap
- $435.0M
- Website
- https://www.emergentbiosolutions.com
Loading EBS…
Loading profile data…Frequently asked questions about EBS
What does Emergent BioSolutions Inc. (EBS) do?
Emergent BioSolutions Inc. is a life sciences company dedicated to providing vital preparedness and response solutions for a wide range of public health threats (PHTs) across the United States. These threats encompass accidental, deliberate, and naturally occurring events, including chemical, biological, radiological, nuclear, and explosives (CB...
Where does EBS trade?
Emergent BioSolutions Inc. (EBS) trades on the New York Stock Exchange.
What sector is EBS in?
Emergent BioSolutions Inc. (EBS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Emergent BioSolutions Inc.?
Joseph C. Papa Jr. is the chief executive officer of Emergent BioSolutions Inc. (EBS).
Where is Emergent BioSolutions Inc. headquartered?
Emergent BioSolutions Inc. is headquartered in United States.
Does EBS pay a dividend?
Emergent BioSolutions Inc. (EBS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EBS go public?
Emergent BioSolutions Inc. (EBS) completed its initial public offering in 2006.